Depigmenting Agents and Hydroquinone
On this page
Direct answer
Depigmenting agents reduce melanin mainly by inhibiting tyrosinase, the copper-containing enzyme that starts melanin synthesis. Hydroquinone is the reference agent, while kojic acid, azelaic acid and tretinoin act through related or complementary routes. Long-term hydroquinone can cause exogenous ochronosis, so its use is limited in duration and concentration, and sun protection remains the foundation of any regimen.
What you must remember
- Tyrosinase: the copper-containing enzyme that converts tyrosine to dopaquinone, the key regulatory step of melanin synthesis.
- Hydroquinone: inhibits tyrosinase and is toxic to melanocytes, commonly used at 2 to 4 percent concentrations under supervision.
- Kojic acid: chelates the copper at the tyrosinase active site, and it can cause contact sensitisation.
- Azelaic acid: inhibits tyrosinase and has antiproliferative and anti-inflammatory effects, and it is generally well tolerated in darker skin.
- Tretinoin: accelerates keratinocyte turnover, which speeds the dispersal of epidermal pigment.
- Triple combination: hydroquinone, tretinoin and a topical steroid used together, with the steroid offsetting irritation.
- Exogenous ochronosis: blue-black or grey-brown pigmentation after long-term hydroquinone use, most often at higher concentrations and in darker skin.
- Mercury: mercury-containing skin-lightening creams cause systemic toxicity and are restricted in many countries.
Choosing an agent by mechanism and risk
The depigmenting agents act at different steps, which explains why they are often combined. The table compares the mechanism and the key adverse effect of each agent.
| Agent | Mechanism | Main adverse effect |
|---|---|---|
| Hydroquinone | Tyrosinase inhibition and melanocyte toxicity | Irritation; ochronosis with long-term use |
| Kojic acid | Copper chelation at the tyrosinase site | Contact dermatitis and sensitisation |
| Azelaic acid | Tyrosinase inhibition, antiproliferative and anti-inflammatory | Transient itching or burning |
| Tretinoin | Faster keratinocyte turnover and pigment dispersal | Erythema, peeling and photosensitivity |
| Triple combination | Hydroquinone, tretinoin and steroid acting together | Steroid atrophy and irritation if prolonged |
Combinations work because each component acts at a different step, and the steroid reduces the irritation caused by the other two. The practical safeguard is a defined duration with review, because cumulative toxicity such as ochronosis accumulates with prolonged use.
Hydroquinone is used for melasma and resistant hyperpigmentation, and it is usually prescribed with a defined review date. Kojic acid or azelaic acid are often preferred when the risk of irritation or ochronosis outweighs the need for faster lightening.
Where the exam tries to catch you
Depigmenting agent questions test mechanism, adverse effects and the limits of use.
- Trap: prescribing hydroquinone indefinitely for melasma. Correct: use it in short, reviewed courses, because exogenous ochronosis and other adverse effects accumulate with long use.
- Trap: attributing blue-black pigment after long hydroquinone use to a fresh melasma flare. Correct: this is exogenous ochronosis, and the agent must be stopped.
- Trap: recommending a mercury-containing cream as a safe lightening option. Correct: mercury causes systemic toxicity, and such products are restricted in many countries and are never an appropriate treatment.
Frequently asked questions
Why is hydroquinone combined with tretinoin and a topical steroid?
The triple combination works because hydroquinone inhibits tyrosinase, tretinoin speeds pigment dispersal, and the steroid reduces the irritation caused by the other two. The combination improves response in melasma and other resistant hyperpigmentation.
What is exogenous ochronosis and what causes it?
Exogenous ochronosis is blue-black or grey-brown pigmentation caused by long-term use of hydroquinone, most often at higher concentrations in darker skin. It results from ochronotic pigment deposition in the dermis, and it can be difficult to reverse once established.
How does kojic acid lighten pigmentation?
Kojic acid inhibits tyrosinase by chelating the copper within its active site, thereby reducing melanin synthesis. It is less potent than hydroquinone and can cause contact dermatitis, so patch testing is useful in patients who develop irritation.
What is the role of azelaic acid in hyperpigmentation?
Azelaic acid inhibits tyrosinase and has antiproliferative and anti-inflammatory effects, making it useful for post-inflammatory and melasma pigmentation. It is generally well tolerated in darker skin, and transient itching or burning is its commonest complaint.